Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of CS060380 in adults with MASH and obesity
CTR20260887Phase 2Active
- Sponsor
- Cascade Pharmaceuticals
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thybetaxor in metabolic dysfunction-associated steatohepatitis (MASH), obesity, sponsored by Cascade Pharmaceuticals. Started Apr 2026; status: active.
02
Drugs
thybetaxor
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)obesity
Beyond the preview
Go deeper on CTR20260887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260887.